We are thrilled to be working with the excellent EU-funded OpenTox project. OpenTox is working to support predictive toxicology, using a variety of human-relevant approaches, to meet the requirements of the REACH legislation and other global toxicological demands.
On 30 October, our US Science Director, Dr Katya Tsaioun, is speaking at the OpenTox USA InterAction meeting on Innovation in Predictive Toxicology. She will also present a poster outlining our groundbreaking proposal to compare the relative abilities of animal tests and human-based in vitro tests to predict the safety of medicines.
World Patient Safety Day is grounded in the most fundamental principle of medicine – first do no harm “Medication Safety” is the theme for World Patient Safety Day 2022. Safer Medicines Trust is a patient safety charity whose mission is to improve the safety of medicines, so we very much support calls for “Medication Without Harm”. The World […]
The crisis of Alzheimer’s disease research: it’s time to embrace a new approach to help patientsThe problem Alzheimer’s disease (AD) is a leading cause of death in the UK and along with other dementias, is responsible for almost 11% of all deaths in England.1 More than 209,000 new cases are diagnosed each year across the UK.2 It remains a leading cause of death and disability worldwide3, affecting nearly 50 million […]
